Published date: 9 June 2021

Last edited date: 11 June 2021

This notice was replaced on 9 June 2021

This notice does not contain the most up-to-date information about this procurement. The most recent notice is:

Opportunity (published 9 June 2021, last edited 29 November 2022)

Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.


Contract summary

Industry

  • Administrative healthcare services - 75122000

Location of contract

SE1 8UG

Value of contract

£0

Procurement reference

CF-0222900D0O000000rwimUAA2

Published date

9 June 2021

Closing date

28 June 2021

Closing time

12pm

Contract start date

1 August 2021

Contract end date

31 July 2022

Contract type

Service contract

Procedure type

Open procedure (below threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements below the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

Public Health England (PHE) is seeking to commission an external partner with an existing system and / or capability to deliver an opioid and new psychoactive substances (NPS) clinical harms surveillance programme. The programme will:
• rapidly detect any incident involving synthetic opioids in the heroin or cocaine markets;
• monitor the emergence of a synthetic opioid market as seen in North America;
• identify health harms associated with toxicity from emerging/new NPS, such as synthetic cannabinoids.

More information

Previous notice about this procurement

PHE - Corporate - Acute Drug Harms Surveillance and Early Warning System in UK

  • Opportunity
  • Published 9 June 2021

About the buyer

Contact name

Jade Palmer

Address

Wellington House, 133-155 Waterloo Road
London
SE1 8UG
GB

Email

jade.palmer@phe.gov.uk